user avatar
Cancer Discovery
@CD_AACR
Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.
Posts
  • Pinned
    user avatar
  • user avatar
    Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. bit.ly/3GkSqZK @Ludwig_Cancer
  • user avatar
    Thanks for joining us for this look back at 2022’s top tweets for articles and reviews. Announcing the top post of 2022: Hallmarks of Cancer-New Dimensions, by Douglas Hanahan. bit.ly/3HZshDI @Ludwig_Cancer —Cancer Discovery top tweets of 2022
  • user avatar
    In the January issue of Cancer Discovery, Hallmarks of Cancer-New Dimensions. bit.ly/3nHy59C Douglas Hanahan, @Ludwig_Cancer
  • user avatar
    OnlineFirst: Structural basis of PML/RARA targeting by arsenic, by @Pierre_Bercier, Qian Qian Wang, Ning Zang, Chun Zhou, Hua Naranmandura, Hugues De Thé, Valérie Lallemand-Breitenbach et al. bit.ly/45GRcov @CirbCdf @Inserm @HopSaintLouis @ZJU_China #Leusm
  • user avatar
    Cancer Discovery's new Impact Factor is 39.397! Thank you to our authors, reviewers and editors for their contributions! bit.ly/2TlGfss
  • user avatar
    Congratulations to our Executive Editor, @ElizSMcKenna, PhD, on being named as one of the nation’s most promising young oncology professionals recognized in “40 Under 40 in Cancer” Class of 2021! bit.ly/3lqpuay
  • user avatar
    In celebration of the new #HallmarksofCancer, we will be sharing each of the 14 parts that have been added to the hallmarks ring over the last 20 years. Be sure to share your favorite! bit.ly/3sC5OmB
  • user avatar
    Our Impact Factor has increased to 29.497! Thank you to the authors, reviewers, editors and readers who made it possible! Source: Clarivate 2020 #JCR2020 aacrjournals.org/site/Info/impa…
  • user avatar
    Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T Cell Exclusion in Human Lung Tumors, by @effiken, @HeleneSalmon et al. bit.ly/3Aw7EcO @institut_curie @IcahnMountSinai @TischCancer #LungCancer
  • user avatar
    In the Spotlight: A splendid new beginning at the end of a 40-year quest: the first KRASG12D inhibitor in #pancreaticcancer, by @alex_redding_ and @EldaGrabocka. bit.ly/3XfEQ1k @KimmelCancerCtr @TJUHospital
  • user avatar
    We proudly present “Hallmarks of Cancer: New Dimensions,” by Douglas Hanahan, the third update to the seminal series.
  • user avatar
    The Hallmarks of Precancer— bit.ly/44cuDbm @MMStangis, Chen, Min, @SciComSarah, Jackson, @radykm, Hoi, Brennen, Yu, @huyqdinh, @Coffey_EGFR, Shrubsole, @research4cure, Grady, Yegnasubramanian, @LyssiotisLab, @Aiims1742, Halberg, @DeySciences @KenLauLab #CancerHallmarks
  • user avatar
    Online now for the #AACR25 session on Advances in #KRAS Biology in PDAC by session speaker @andrewaguirremd: Response and Resistance to RAS inhibition in Cancer brnw.ch/21wSgTw